GSK Offers $28M To Settle Suits Over Defective Paxil

Law360, New York (March 2, 2009, 12:00 AM EST) -- GlaxoSmithKline PLC has agreed to pay $28 million to settle two proposed class actions over claims that the company's Puerto Rico plant produced defective versions of the company's antidepressant Paxil CR that caused the pills to split apart into their active ingredient and controlled release halves.

Judge Gustavo Gelpi of the U.S. District Court for the District of Puerto Rico gave the proposed settlement and request for class certification preliminary approval Monday, with a fairness hearing set for July.

The arrangement would provide up to $11.2...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Simonet v. GlaxoSmithkline et al


Case Number

3:06-cv-01230

Court

Puerto Rico

Nature of Suit

Personal Inj. Prod. Liability

Judge

Gustavo A. Gelpi

Date Filed

March 6, 2006

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.